European Society of Cardiology Congress

Cardiology Today and Healio are pleased to offer highlights from the European Society of Cardiology Congress in Paris. Visit this page often for the latest news, video interviews and more. Also follow @CardiologyToday on Twitter for continuing updates.

Meeting NewsPerspective

ASCEND: Aspirin, omega-3 supplements fail for primary prevention in diabetes

August 26, 2018
MUNICH — In a large cohort of patients with diabetes but no prior CVD, aspirin prevented vascular events but caused major bleeding events, and…
Meeting NewsPerspective

Outcomes of single, bilateral internal thoracic artery grafting similar at 10 years

August 26, 2018
MUNICH — Among patients undergoing CABG, routine bilateral internal thoracic artery grafting and routine single internal thoracic artery…
Meeting NewsPerspective

No excess CV risk with lorcaserin for weight loss

August 26, 2018
MUNICH — Treatment with the serotonin receptor agonist lorcaserin yielded sustained weight loss over a median follow-up of 3 years without an…
Meeting NewsPerspective

ARRIVE: Aspirin does not reduce initial vascular events in low-to-moderate risk population

August 26, 2018
MUNICH — In a moderate-risk population with low event rates, aspirin did not significantly reduce initial vascular events, according to the…
Meeting NewsPerspective

Results mixed on rivaroxaban for extended thromboprophylaxis in MARINER

August 26, 2018
MUNICH — In medically ill patients at risk for venous thromboembolism, rivaroxaban did not improve the composite endpoint of symptomatic VTE or…
Meeting News

In CV research, academic-industry collaborations can fuel new advances

August 26, 2018
MUNICH — The history of cardiovascular discoveries is rooted in the collaboration of researchers from academia and industry, who share common…
Meeting News

SGLT2 inhibitor therapies may raise risk for amputation, diabetic ketoacidosis in diabetes with CVD

August 25, 2018
MUNICH — Adults with type 2 diabetes and established CVD prescribed SGLT2 inhibitor therapy have a twofold increased risk for lower-limb…
Meeting NewsPerspective

MATRIX: Radial access lowers net events vs. femoral access at 1 year

August 25, 2018
MUNICH — At 1 year, a strategy of transradial access for coronary angiography, followed by PCI if indicated, conferred lower net adverse…
Meeting News

Evolocumab shows CV benefit in metabolic syndrome

August 25, 2018
MUNICH — Adults with metabolic syndrome assigned to treatment with the PCSK9 inhibitor evolocumab experienced a greater absolute risk reduction…
Meeting NewsPerspective

CULPRIT-SHOCK: Culprit-only PCI maintains advantage at 1 year for cardiogenic shock, multivessel disease

August 25, 2018
MUNICH — At 1 year, risk for death or renal replacement therapy was lower among patients with acute MI, cardiogenic shock and multivessel CAD…